• Prochlorperazine: Translational Bridges from Antiemesis to A

  2026-06-23

  Explore Prochlorperazine as a dopamine D2 receptor antagonist with emerging roles in antiemetic therapy, melanoma research, and acute mountain sickness prevention. This article offers a deep, cross-domain analysis, including unique protocol recommendations and insights from the latest clinical research.

• Paclitaxel (Taxol): Morphological Profiling and Cell Cycle I

  2026-06-23

  Explore how Paclitaxel (Taxol) revolutionizes cancer research through quantitative morphological profiling and advanced cell cycle analysis. This article offers a unique perspective on leveraging high-content imaging and machine learning to decode the mechanism of action, with practical protocol guidance.

• Advancing Cell Assay Reliability with Angiotensin (1-7)

  2026-06-22

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Angiotensin (1-7) (SKU A1041) from APExBIO delivers reproducible, data-backed solutions. By integrating scenario-driven Q&A blocks, we highlight the peptide’s mechanistic strengths, ultra-high purity, and workflow adaptability for biomedical researchers.

• Methotrexate: Mechanistic Insights as a Folate Antagonist

  2026-06-22

  Methotrexate is a well-established folate antagonist that exerts immunosuppressive and anti-inflammatory effects through dihydrofolate reductase inhibition, adenosine modulation, and apoptosis induction in activated T cells. Its mechanism is highly relevant for research into immune modulation and apoptosis. New partitioning models and robust protocols support its versatile use in preclinical studies.

• Diclofenac as a Non-Selective COX Inhibitor: Precision Tools

  2026-06-21

  Discover how Diclofenac, a non-selective COX inhibitor, advances inflammation and pharmacokinetic research by bridging high-purity compound sourcing with the latest stem cell-derived intestinal organoid models. This article uncovers nuanced experimental strategies and protocol insights not addressed elsewhere.

• Periodontopathogen Proteases Generate Angiotensin (1-7) In S

  2026-06-20

  This study reveals that periodontopathogenic bacteria Porphyromonas gingivalis and Tannerella forsythia can directly degrade angiotensin I to generate the anti-inflammatory peptide Angiotensin (1-7) via surface-attached PepO metalloproteases. These findings uncover a novel microbial mechanism for local renin–angiotensin system modulation, linking oral dysbiosis to systemic RAS peptide profiles and offering new perspectives for cross-disciplinary research.

• Universal nPEC Method for Dual-Loaded Liposome Encapsulation

  2026-06-19

  This study presents a robust, universally applicable nanoparticle exclusion chromatography (nPEC) method for accurately determining the encapsulation efficiency of dual-loaded liposomes with both hydrophilic and lipophilic drugs. The findings address a longstanding technical barrier in drug delivery, enabling more precise formulation and assessment for combination therapies.

• Tetrahydromagnolol: Peripheral CB2 Receptor Agonist for Meta

  2026-06-19

  Tetrahydromagnolol empowers researchers to precisely interrogate peripheral CB2 signaling and metastatic mechanisms in GPCR-driven models. Its high selectivity and potency streamline anti-inflammatory and cell migration studies where conventional CB2 agonists fall short.

• Pentoxifylline: Beyond Inflammation—Mechanistic Depth in Mal

  2026-06-18

  Explore Pentoxifylline’s unique dual role as a phosphodiesterase inhibitor and anti-inflammatory compound in both immune modulation and male infertility research. This article delivers advanced mechanistic insight, practical protocol guidance, and evidence-driven analysis not covered in other reviews.

• Genetic Dissection of the IPA Pathway for Auxin in Neurospor

  2026-06-18

  This study delivers the first comprehensive genetic and biochemical analysis of the indole-3-pyruvic acid (IPA) pathway for indole-3-acetic acid (IAA) biosynthesis in the fungus Neurospora crassa. By mapping homologous genes and validating their function, the research establishes a critical framework for cross-kingdom auxin studies and highlights key regulatory steps and physiological impacts.

• Chronic Stress, Mitochondrial Dysfunction, and MnTBAP Rescue

  2026-06-17

  This study establishes that chronic unpredictable mild stress (CUMS) induces depression-like behaviors in rats by impairing mitochondrial function and heightening neuroinflammation in the brain. Notably, intracerebroventricular administration of MnTBAP, a mitochondrial-targeted SOD mimetic, ameliorates these behavioral and molecular effects, clarifying the mechanistic interplay between redox imbalance and inflammatory signaling in stress-induced depression models.

• Phenacetin in Translational Pharmacokinetics: Mechanisms & S

  2026-06-17

  This article delivers a mechanistic and strategic perspective on the role of Phenacetin (N-(4-ethoxyphenyl)acetamide) in next-generation pharmacokinetic models, highlighting its value in human-relevant in vitro systems, solubility optimization, and translational rigor. Drawing on recent research and competitive benchmarks, we provide actionable protocol guidance, discuss implications for nephropathy risk modeling, and offer a forward-looking outlook for translational researchers.

• Pharmacokinetic Variability of CSBTA in MASH Mouse Models

  2026-06-16

  This study systematically investigates the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in high-fat, high-cholesterol diet-induced mouse models of metabolic dysfunction-associated steatohepatitis (MASH). The findings reveal how pathological states and transporter/enzyme modulation significantly alter drug disposition, providing critical guidance for optimizing dosing regimens in MASLD/MASH research.

• Methotrexate: Folate Antagonist Mechanisms & Research Benchm

  2026-06-16

  Methotrexate is a well-characterized folate antagonist with potent immunosuppressive and anti-inflammatory properties. Its mechanism centers on dihydrofolate reductase inhibition, apoptosis induction in activated T cells, and adenosine-mediated inflammation control. This article consolidates protocol parameters, peer-reviewed evidence, and practical limitations for robust research design.

• Morin: Precision Targeting of Mitochondrial Stress in Diabet

  2026-06-15

  Explore how Morin, a natural flavonoid, precisely modulates mitochondrial energy metabolism by inhibiting adenosine 5′-monophosphate deaminase. This in-depth analysis reveals unique insights into Morin's mechanistic role in diabetic kidney injury, advancing its value beyond standard protocols.

15480 records 1/1032 page Next 12345 下5页 Last page